Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitman, S. P.
Right arrow Articles by Daniel, L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitman, S. P.
Right arrow Articles by Daniel, L. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 38, Issue of September 19, 1997 pp. 23481-23484
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

COMMUNICATION:
Protein Kinase Cbeta II Activation by 1-beta -D-Arabinofuranosylcytosine Is Antagonistic to Stimulation of Apoptosis and Bcl-2alpha Down-regulation

(Received for publication, June 11, 1997, and in revised form, July 22, 1997)

Susan P. Whitman , Francesca Civoli and Larry W. Daniel

From the Department of Biochemistry, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157-1016

1-beta -D-Arabinofuranosylcytosine (ara-C) stimulates the formation of both diglyceride and ceramide in the acute myelogenous leukemia cell line HL-60 (Strum, J. C., Small, G. W., Pauig, S. B., and Daniel, L. W. (1994) J. Biol. Chem 269, 15493-15497). ara-C also causes apoptosis in HL-60 cells which can be mimicked by exogenous ceramide. However, the signaling role for ara-C-induced diacylglycerol (DAG) is not defined. We found that Bcl-2 levels were increased by treatment of HL-60 cells with exogenous DAG or 12-O-tetradecanoylphorbol-13-acetate (TPA). In contrast, exogenous ceramide treatment caused a decrease in cellular Bcl-2 levels. Thus, ara-C stimulates the synthesis of two second messengers with opposing effects on Bcl-2. Since the effects of ara-C-induced DAG could be due to protein kinase C (PKC) activation, we determined the effects of ara-C on PKC isozymes. ara-C caused an increase in membrane-bound PKCbeta II (but not PKCalpha or PKCdelta ). ara-C or TPA-induced translocation of PKCbeta II was inhibited by 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3), and ara-C-induced apoptosis was stimulated by pretreatment of the cells with ET-18-OCH3. ET-18-OCH3 also inhibited stimulation of Bcl-2 by TPA and enhanced the decrease in Bcl-2 observed in ara-C-treated cells. These data indicate that ara-C-induced apoptosis is limited by ara-C-stimulated PKCbeta II through effects on Bcl-2. To further determine the role of PKC, we used antisense oligonucleotides directed toward PKCbeta II. The antisense, but not the sense, oligonucleotide inhibited PKCbeta II activation and enhanced ara-C-induced apoptosis. These data demonstrate that the stimulation of apoptosis by ara-C is self-limiting and can be enhanced by inhibition of PKC.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
K. V. Ramana, B. Friedrich, R. Tammali, M. B. West, A. Bhatnagar, and S. K. Srivastava
Requirement of Aldose Reductase for the Hyperglycemic Activation of Protein Kinase C and Formation of Diacylglycerol in Vascular Smooth Muscle Cells
Diabetes, March 1, 2005; 54(3): 818 - 829.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Tenzer, D. Zingg, S. Rocha, B. Hemmings, D. Fabbro, C. Glanzmann, P. A. Schubiger, S. Bodis, and M. Pruschy
The Phosphatidylinositide 3'-Kinase/Akt Survival Pathway Is a Target for the Anticancer and Radiosensitizing Agent PKC412, an Inhibitor of Protein Kinase C
Cancer Res., November 1, 2001; 61(22): 8203 - 8210.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. Dent and S. Grant
Pharmacologic Interruption of the Mitogen-activated Extracellular-regulated Kinase/Mitogen-activated Protein Kinase Signal Transduction Pathway: Potential Role in PromotingCytotoxic Drug Action
Clin. Cancer Res., April 1, 2001; 7(4): 775 - 783.
[Full Text]


Home page
Cancer Res.Home page
K. Zaugg, S. Rocha, H. Resch, I. Hegyi, C. Oehler, C. Glanzmann, D. Fabbro, S. Bodis, and M. Pruschy
Differential p53-dependent Mechanism of Radiosensitization in Vitro and in Vivo by the Protein Kinase C-specific Inhibitor PKC412
Cancer Res., January 1, 2001; 61(2): 732 - 738.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
P. A. Kirkham, H.-H. Takamatsu, E. W.-F. Lam, and R. M. E. Parkhouse
Ligation of the WC1 Receptor Induces {gamma}{delta} T Cell Growth Arrest Through Fumonisin B1-Sensitive Increases in Cellular Ceramide
J. Immunol., October 1, 2000; 165(7): 3564 - 3570.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
S. Rocha, M. S. Soengas, S. W. Lowe, C. Glanzmann, D. Fabbro, K. Winterhalter, S. Bodis, and M. Pruschy
Protein Kinase C Inhibitor and Irradiation-induced Apoptosis: Relevance of the Cytochrome c-mediated Caspase-9 Death Pathway
Cell Growth Differ., September 1, 2000; 11(9): 491 - 499.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. Fujii, M. L. Garcia-Bermejo, J. L. Bernabo, J. Caamano, M. Ohba, T. Kuroki, L. Li, S. H. Yuspa, and M. G. Kazanietz
Involvement of Protein Kinase C delta (PKCdelta ) in Phorbol Ester-induced Apoptosis in LNCaP Prostate Cancer Cells. LACK OF PROTEOLYTIC CLEAVAGE OF PKCdelta
J. Biol. Chem., March 10, 2000; 275(11): 7574 - 7582.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Nechushtan, M. Leitges, C. Cohen, G. Kay, and E. Razin
Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cbeta
Blood, March 1, 2000; 95(5): 1752 - 1757.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
N. SCHIAVONE, P. ROSINI, A. QUATTRONE, M. DONNINI, A. LAPUCCI, L. CITTI, A. BEVILACQUA, A. NICOLIN, and S. CAPACCIOLI
A conserved AU-rich element in the 3' untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis
FASEB J, January 1, 2000; 14(1): 174 - 184.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Tan, H. Ruan, M. R. Demeter, and M. J. Comb
p90RSK Blocks Bad-mediated Cell Death via a Protein Kinase C-dependent Pathway
J. Biol. Chem., December 3, 1999; 274(49): 34859 - 34867.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Y. Song, M. Ailenberg, and M. Silverman
Human munc13 Is a Diacylglycerol Receptor that Induces Apoptosis and May Contribute to Renal Cell Injury in Hyperglycemia
Mol. Biol. Cell, May 1, 1999; 10(5): 1609 - 1619.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
W. D. Jarvis, F. A. Fornari Jr., R. M. Tombes, R. K. Erukulla, R. Bittman, G. K. Schwartz, P. Dent, and S. Grant
Evidence for Involvement of Mitogen-Activated Protein Kinase, Rather than Stress-Activated Protein Kinase, in Potentiation of 1-beta -D-Arabinofuranosylcytosine-Induced Apoptosis by Interruption of Protein Kinase C Signaling
Mol. Pharmacol., November 1, 1998; 54(5): 844 - 856.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement